Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 4—April 2006

Dispatch

Immune Restoration Disease in HIV Patient

Neil E. Jenkins*Comments to Author , Mike B.J. Beadsworth*, James J. Anson*, Fred J. Nye*, Vanessa J. Martlew*, and Nick J. Beeching*
Author affiliations: *Liverpool School of Tropical Medicine, Liverpool, United Kingdom

Main Article

Figure 1

Chest radiographs at initiation of A) highly active antiretroviral therapy (HAART) showing left hilar mass; and B) after 9 weeks of HAART and antituberculosis treatment, suggesting enlargement of the hilar mass consistent with immune restoration disease. (The radiograph has been flipped horizontally to aid comparison).

Figure 1. Chest radiographs at initiation of A) highly active antiretroviral therapy (HAART) showing left hilar mass; and B) after 9 weeks of HAART and antituberculosis treatment, suggesting enlargement of the hilar mass consistent with immune restoration disease. (The radiograph has been flipped horizontally to aid comparison).

Main Article

TOP